Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CSER _CC_NCGL, |
RCV000417288 | SCV000503521 | uncertain significance | Brugada syndrome | 2016-10-01 | criteria provided, single submitter | research | Found in patient having exome sequencing for an unrelated indication. No known history of Brugada syndrome. This interpretation considers GERP score and allele frequency data, in addition to published reports of the variant in the literature, available at the time of review. |
Gene |
RCV000498848 | SCV000590484 | uncertain significance | not provided | 2024-07-29 | criteria provided, single submitter | clinical testing | Identified in patients with Type 1 diabetes and proliferative diabetic retinopathy (PDR) in published literature (PMID: 31439644); In silico analysis supports that this missense variant does not alter protein structure/function; Also known as p.(R476C); Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (PMID: 25741868); This variant is associated with the following publications: (PMID: 31439644, 25741868) |
Labcorp Genetics |
RCV001086385 | SCV000647062 | likely benign | Brugada syndrome 4 | 2023-10-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619934 | SCV000736211 | likely benign | Cardiovascular phenotype | 2022-05-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |